Stent Restenosis Clinical Trial
Official title:
Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting
Intrastent restenosis is a common complication after intracranial and extracranial arterial stenting and an important cause of recurrent ischemic stroke. Studies have shown that Tongxinluo capsule can protect the injured inner cells, reduce inflammation, inhibit the proliferation and migration of smooth muscle cells, inhibit the proliferation of plaque and nourish blood vessels, and resist arteriosclerosis. This study was a multicenter prospective randomized controlled clinical trial. Participants with intracranial and extracranial atherosclerotic stenosis who successfully underwent arterial stenting were included in the study, and were divided into Tongxinluo test group and control group. Clinical and related auxiliary examination data were collected at each follow-up point. To explore the effectiveness and potential mechanism of Tongxinluo capsule in preventing and treating restenosis after intracranial and external arterial stenting, and to provide reference for expanding clinical use of traditional Chinese medicine.
Study participants aged 45-80 years who met the criteria for symptomatic or asymptomatic cerebral artery stenosis and successfully underwent cerebrovascular stenting were randomly divided into test group and control group. On the basis of routine oral treatment ,participants in experimental group were given Tongxinluo capsule. The control group received routine oral treatment. The routine follow-up sites were 1, 3, 6 and 12 months, and clinical data and blood were collected at the initial diagnosis and each follow-up site. SPSS software was used to analyze whether Tongxinluo capsule could reduce restenosis after intracranial and extracranial arterial stenting. During the follow-up, the adverse reactions such as bleeding and gastrointestinal tract were observed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05591365 -
Exercise Training in Coronary Artery Disease Patients After Stenting
|
N/A | |
| Completed |
NCT05315193 -
Effect of Exercise Training in Coronary Artery Disease Patients After Stenting
|
N/A | |
| Active, not recruiting |
NCT03097679 -
Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions
|
N/A | |
| Recruiting |
NCT05346068 -
The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial
|
N/A | |
| Active, not recruiting |
NCT03349385 -
Registry of Secondary Revascularization
|
||
| Recruiting |
NCT04325867 -
Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19
|
N/A | |
| Recruiting |
NCT05244629 -
Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia
|
N/A | |
| Completed |
NCT03544294 -
veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study
|
||
| Completed |
NCT05217459 -
The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease
|
N/A | |
| Recruiting |
NCT05205148 -
Ultrathin DES in Complex PCI Scenarios: the ULTRA a Multicenter Study
|
||
| Not yet recruiting |
NCT03375528 -
Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation
|
N/A | |
| Completed |
NCT06276114 -
IVL vs ELCA for Stent Underexpantsion (IVL-ELCA DRAGON)
|